News
Innovative Medicines based on
ImmunoModulatory Biologics
-
Media Room
-
News
IMBiologics, ‘Bispecific Antibody’ approved for phase 1 in the US, entering the second half of the year.
-
- Date
- 2023-08-01 13:32:50
-
- View
- 1074
- President(CEO) : Gyongsik Ha
- 260, Changnyong-daero, Yeongtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea